The Henry M. Jackson Foundation for the Advancement of Military Medicine, Inc., acknowledges the generous support of the following companies...

Exhibitors

new alcon logo

Alcon is the global leader in eye care. As a division of Novartis, we offer the broadest portfolio of products to enhance sight and improve people’s lives. Our products touch the lives of more than 285 million people each year living with conditions like cataracts, glaucoma, retinal diseases and refractive errors, and there are millions more who are waiting for solutions to meet their eye care needs. Our purpose is reimagining eye care, and we do this through innovative products, partnerships with eye care professionals and programs that enhance access to quality eye care.  Learn more at www.alcon.com

ArcScan

The next generation of anterior segment imaging for ophthalmology is the ArcScan Insight 100. The Insight 100 provides complete visualization of the true anatomy of the entire anterior segment, including behind the iris. Because of its proprietary technology, all images from the Insight 100 depict the true anatomy of the entire anterior segment; and delivers real, reproducible measurements that can be used to guide surgical planning, treatment and care. The image results offer precise anterior chamber depth, angle-to-angle width, individual corneal layers, sulcus-to-sulcus width measurements. Tamil M. Singh, Vice President of Sales & Marketing, ArcScan, Inc., mobile: +1 904.422.5298, direct: +1 720.773.8550 x107, toll free: +1 877.363.SCAN (7226) email: tsingh@arcscan.com, web: www.arcscan.com  

Allergan_Logo_Tm

Allergan PLC (NYSE:AGN) is a bold, global pharmaceutical company with commercial operations in approximately 100 countries. Allergan is committed to working with physicians, healthcare providers, and patients to deliver innovative and meaningful treatments that help people around the world live longer, healthier lives. XEN builds on Allergan's deep and long-standing commitment to eye care providers and their patients.  www.xengelstent.com  www.allergan.com

octovue

Optovue is a privately held medical device company founded by Jay Wei in 2003 to develop the next generation of ophthalmic optical coherence tomography (OCT) instruments. The company is dedicated to working with eye care professionals and clinical researchers to lead the development and commercialization of high-speed OCT and OCT angiography (OCTA), used to facilitate the visualization and management of eye diseases, many of which may lead to permanent blindness.  www.optovue.com 1-866-344-8948

STAAR logo  

STAAR designs, manufactures and markets implantable lenses for the eye with companion delivery systems. These lenses are intended to provide visual freedom for patients, lessening or eliminating the reliance on glasses or contact lenses. These lenses are foldable, which permits the surgeon to insert them through a small incision. www.staar.com discovericl.com. For more information contact STAAR Surgical Customer Service: customerservice@staar.com Phone: 626.303.7902


surgilum

Surgilūm founder, Alan W. Brown MD has a goal to "help surgeons see." By offering first in class solutions to frequently encountered surgical problems, Surgilūm products are easy to use, safe, efficient, and cost effective. From the award winning Robomarker system for asigmatism management to the RoboLight, Surgilūm's newest innovation for transillumination of the cornea, Surgiūm products add a level of confidence and productivity to every case. The disposable aspect of each product enables ASC owners to keep costs down while eliminating any concerns of TASS. surgilum.com Sales: Debbie Brown debbie@surgilum.com 910-202-2202

The Mynosys ZeptoTM Capsulotomy System  is a surgical instrument for intervention in the eye.  It consists of a power console and disposable handpieces based on the use of short energy pulses to create the rapid phase transition of water molecules, in or near tissues, to create a tissue cutting force.   ZeptoTM provides a means for surgeons  to create  round, centered and strong capsulotomy openings that are  consistent in shape, size and aligned to the patients visual axis each time.TM

zepto

The Mynosys Zepto Capsulotomy System is a surgical instrument for intervention in the eye.  It consists of a power console and disposable handpieces based on the use of short energy pulses to create the rapid phase transition of water molecules, in or near tissues, to create a tissue cutting force. Zepto provides a means for surgeons to create round, centered and strong capsulotomy openings that are consistent in shape, size and aligned to the patients visual axis each time. Distributed through Corps Medical Supply * www.corpsmedicalsupply.com * 855-991-2020

Regeneron_logo_Blue_L 
Regeneron (NASDAQ: REGN) is a leading science and technology company delivering life-transforming medicines for serious diseases. Founded by physician-scientists nearly 30 years ago, our science-driven approach has resulted in six FDA-approved medicines and numerous product candidates in a range of diseases, including asthma, pain, cancer and infectious diseases. Contact Steve Wirtz, Associate Director, Federal Markets, 914-262-1663 * www.regeneron.com

zeiss logo

Carl Zeiss Meditec AG offers complete solutions, including implants and consumables, to diagnose and treat eye conditions and ophthalmic diseases. The comprehensive ZEISS portfolio is designed to meet the demands of eye care professionals and help them deal with an increasingly challenging healthcare environment. www.zeiss.com/corporate/us/home.html

LENSAR

We are the leader in next-generation femtosecond laser technology for refractive cataract surgery because we not only understand the needs of surgeons and their patients today, but also stay on top of trends so we can innovate our technology to ensure we meet their needs in the future. As a result, we have been rapidly advancing our technology and have just launched our third system upgrade in two years, Streamline® III. Recently, LENSAR has launched a program to bring this technology to the Armed Forces. John Leeth, Manager of Corporate Accounts - US 2800 Discovery Drive Orlando, Fl 32826 www.lensar.com Cell 540.230.9964 john.leeth@lensar.com

Outlook Outlook
iCal iCal
Google Google
Yahoo! Yahoo!
MSN MSN
Top